Theseus Pharmaceuticals Inc (DELISTED) (THRX:DL)
4.06
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Theseus Pharmaceuticals Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| February 23, 2024 | -25.55M |
| February 22, 2024 | -25.55M |
| February 21, 2024 | -25.55M |
| February 20, 2024 | -25.55M |
| February 16, 2024 | -25.55M |
| February 15, 2024 | -25.55M |
| February 14, 2024 | -25.55M |
| February 13, 2024 | -25.55M |
| February 12, 2024 | -25.55M |
| February 09, 2024 | -25.11M |
| February 08, 2024 | -25.55M |
| February 07, 2024 | -24.66M |
| February 06, 2024 | -24.66M |
| February 05, 2024 | -25.11M |
| February 02, 2024 | -25.55M |
| February 01, 2024 | -24.66M |
| January 31, 2024 | -25.55M |
| January 30, 2024 | -25.55M |
| January 29, 2024 | -26.87M |
| January 26, 2024 | -28.20M |
| January 25, 2024 | -28.64M |
| January 24, 2024 | -28.20M |
| January 23, 2024 | -28.20M |
| January 22, 2024 | -28.64M |
| January 19, 2024 | -28.20M |
| Date | Value |
|---|---|
| January 18, 2024 | -28.20M |
| January 17, 2024 | -27.76M |
| January 16, 2024 | -28.64M |
| January 12, 2024 | -26.87M |
| January 11, 2024 | -28.64M |
| January 10, 2024 | -29.09M |
| January 09, 2024 | -28.64M |
| January 08, 2024 | -28.20M |
| January 05, 2024 | -29.53M |
| January 04, 2024 | -28.64M |
| January 03, 2024 | -29.09M |
| January 02, 2024 | -28.20M |
| December 29, 2023 | -25.99M |
| December 28, 2023 | -20.24M |
| December 27, 2023 | -21.12M |
| December 26, 2023 | -22.01M |
| December 22, 2023 | -23.78M |
| December 21, 2023 | -41.47M |
| December 20, 2023 | -43.68M |
| December 19, 2023 | -37.49M |
| December 18, 2023 | -41.91M |
| December 15, 2023 | -39.26M |
| December 14, 2023 | -36.61M |
| December 13, 2023 | -37.49M |
| December 12, 2023 | -41.03M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-111.37M
Minimum
Oct 27 2023
687.13M
Maximum
Nov 19 2021
109.55M
Average
66.91M
Median
Enterprise Value Benchmarks
| Karuna Therapeutics Inc (DELISTED) | 11.34B |
| NovaBay Pharmaceuticals Inc | 2.833M |
| Palatin Technologies Inc | 11.39M |
| iBio Inc | 5.346M |
| Theriva Biologics Inc | -13.34M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.50M |
| Total Expenses (Quarterly) | 16.40M |
| EPS Diluted (Quarterly) | -0.31 |